MENU
+Compare
ACBD
Stock ticker: OTC
AS OF
Jun 11 closing price
Price
$0.60
Change
-$0.20 (-25.00%)

ACBD Annabidiol Corp. Forecast, Technical & Fundamental Analysis

Annabidiol Corp is a shell company... Show more

ACBD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ACBD with price predictions
Jul 03, 2025

ACBD in upward trend: price may ascend as a result of having broken its lower Bollinger Band on June 12, 2025

ACBD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 11 cases where ACBD's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 13 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Momentum Indicator moved above the 0 level on June 26, 2025. You may want to consider a long position or call options on ACBD as a result. In of 45 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ACBD just turned positive on June 20, 2025. Looking at past instances where ACBD's MACD turned positive, the stock continued to rise in of 35 cases over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Aroon Indicator for ACBD entered a downward trend on June 30, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (237.949). P/E Ratio (0.000) is within average values for comparable stocks, (160.134). Dividend Yield (0.000) settles around the average of (0.104) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (155.883).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ACBD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACBD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ACBD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry FinancialConglomerates

Profile
Fundamentals
Details
Industry
N/A
Address
P.O. Box 174
Phone
+1 978 225-3456
Employees
N/A
Web
N/A
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BBUC32.350.84
+2.67%
Brookfield Business Corp
ATHE4.150.11
+2.64%
Alterity Therapeutics Limited
G45.920.93
+2.07%
Genpact Limited
TFINP22.000.22
+1.01%
Triumph Financial
SATL3.560.02
+0.56%
Satellogic Inc

ACBD and Stocks

Correlation & Price change

A.I.dvisor tells us that ACBD and GGAAF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ACBD and GGAAF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACBD
1D Price
Change %
ACBD100%
N/A
GGAAF - ACBD
24%
Poorly correlated
N/A
HYAC - ACBD
16%
Poorly correlated
-0.18%
AASP - ACBD
4%
Poorly correlated
N/A
GRAF - ACBD
0%
Poorly correlated
-0.19%
AMLTF - ACBD
-0%
Poorly correlated
N/A
More

Groups containing ACBD

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACBD
1D Price
Change %
ACBD100%
N/A
Financial Conglomerates
industry (148 stocks)
8%
Poorly correlated
-0.32%